Trial Profile
An Open-Label Study to Assess the Rate of Failure of an Enbrel® (Etanercept) SureClick™ Auto-injector in Subjects With Rheumatoid Arthritis
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 24 Jan 2020
Price :
$35
*
At a glance
- Drugs Etanercept (Primary)
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- Sponsors Amgen
- 19 Feb 2009 Trial location (USA) added as reported by ClinicalTrials.gov.
- 21 Sep 2008 Actual end date (Jul 06) added as reported by ClinicalTrials.gov.
- 21 Sep 2008 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.